Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

140 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Surgical window of opportunity trial reveals mechanisms of response and resistance to navtemadlin (KRT-232) in patients with recurrent glioblastoma.
Rendo V, Lee EQ, Bossi C, Khuu N, Rudek MA, Pal S, Reynolds ARN, Fassinou ACR, Ayoub G, Lapinskas E, Pisano W, Jeang J, Stopka SA, Regan MS, Spetz J, Desai A, Lieberman F, Fisher JD, Pelton K, Huang RY, Nabors LB, Holdhoff M, Danda N, Strowd R, Desideri S, Walbert T, Ye X, Agar NYR, Grossman SA, Alexander BM, Wen PY, Ligon KL, Beroukhim R. Rendo V, et al. Among authors: lee eq. medRxiv [Preprint]. 2024 Aug 14:2024.08.12.24311893. doi: 10.1101/2024.08.12.24311893. medRxiv. 2024. PMID: 39211865 Free PMC article. Preprint.
Epidemiology of brain metastases.
Nayak L, Lee EQ, Wen PY. Nayak L, et al. Among authors: lee eq. Curr Oncol Rep. 2012 Feb;14(1):48-54. doi: 10.1007/s11912-011-0203-y. Curr Oncol Rep. 2012. PMID: 22012633
Central nervous system complications of cancer therapy.
Rinne ML, Lee EQ, Wen PY. Rinne ML, et al. Among authors: lee eq. J Support Oncol. 2012 Jul-Aug;10(4):133-41. doi: 10.1016/j.suponc.2011.11.002. Epub 2012 Apr 27. J Support Oncol. 2012. PMID: 22542045 Review.
Neurologic complications of cancer drug therapies.
Lee EQ, Arrillaga-Romany IC, Wen PY. Lee EQ, et al. Continuum (Minneap Minn). 2012 Apr;18(2):355-65. doi: 10.1212/01.CON.0000413663.42798.64. Continuum (Minneap Minn). 2012. PMID: 22810132 Review.
Treatment options in newly diagnosed glioblastoma.
Lee EQ, Nayak L, Wen PY, Reardon DA. Lee EQ, et al. Curr Treat Options Neurol. 2013 Jun;15(3):281-8. doi: 10.1007/s11940-013-0226-9. Curr Treat Options Neurol. 2013. PMID: 23553038
Phase 2 study of dose-intense temozolomide in recurrent glioblastoma.
Norden AD, Lesser GJ, Drappatz J, Ligon KL, Hammond SN, Lee EQ, Reardon DR, Fadul CE, Plotkin SR, Batchelor TT, Zhu JJ, Beroukhim R, Muzikansky A, Doherty L, Lafrankie D, Smith K, Tafoya V, Lis R, Stack EC, Rosenfeld MR, Wen PY. Norden AD, et al. Among authors: lee eq. Neuro Oncol. 2013 Jul;15(7):930-5. doi: 10.1093/neuonc/not040. Epub 2013 Apr 3. Neuro Oncol. 2013. PMID: 23553268 Free PMC article. Clinical Trial.
Update on bevacizumab and other angiogenesis inhibitors for brain cancer.
Rinne ML, Lee EQ, Nayak L, Norden AD, Beroukhim R, Wen PY, Reardon DA. Rinne ML, et al. Among authors: lee eq. Expert Opin Emerg Drugs. 2013 Jun;18(2):137-53. doi: 10.1517/14728214.2013.794784. Epub 2013 May 14. Expert Opin Emerg Drugs. 2013. PMID: 23668489 Review.
140 results